Clinical

Driving Gene Therapy Forward

Driving Gene Therapy Forward

In 2000, recognizing the involvement of ASHG members in gene therapy research and implementation, ASHG issued a statement commenting on the need for rigorous research and consideration of patient interests. Related: Statement on Gene Therapy (August 2000) Read More

Addressing Tandem MS in Newborn Screening

Addressing Tandem MS in Newborn Screening

ASHG and the American College of Medical Genetics issued a 2000 statement describing tandem mass spectrometry and its potential role in newborn screening programs. The statement describes the state of the science as well as questions to be considered in its implementation, including funding and training. Related: Statement on Tandem Mass Spectrometry in Newborn Screening... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy